Clinical trial
Cyclophosphamide Drug Interaction Study In Cancer Patients
NCT00334646 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00334646 |
|---|---|
| Title | Cyclophosphamide Drug Interaction Study In Cancer Patients |
| Official title | An Open Label, Repeat Dose, Randomized, Two Period Crossover Study to Investigate the Potential Pharmacokinetic Interactions Between Oral GW679769 and Intravenous Cyclophosphamide in Cancer Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | Oral GW679769, IV Cyclophosphamide 500-700mg/m2 |
| Enrollment | 25 |
| Start date | Aug 10, 2005 |
| Primary completion | Oct 14, 2009 |
| Completion | Oct 14, 2009 |
| First posted | Jun 8, 2006 |
| Last update posted | Nov 17, 2017 |
| Countries | New Zealand, Sweden, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: